Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Anticancer Drugs
100%
3D Tumor Model
100%
Treatment Strategy
50%
Tumor Heterogeneity
33%
Recent Advances
33%
Current Treatment
33%
Platform Technology
33%
In Cancer
16%
Cancer Patients
16%
Tumor
16%
Glioblastoma
16%
Personalized Therapy
16%
Unmet Needs
16%
Drug Discovery
16%
Three-dimensional (3D)
16%
Poor Prognosis
16%
High Cost
16%
Tumor Microenvironment
16%
Cancer Types
16%
Predictive Power
16%
High-throughput Screening
16%
Improved Outcomes
16%
Chemoresistance
16%
Tumor Model
16%
Cancer Burden
16%
Survival Rate
16%
Microfluidics
16%
Physiologically Relevant
16%
Metastatic Disease
16%
Systemic Therapy
16%
Drug Toxicity
16%
Human Physiology
16%
Ethical Issues
16%
Treatment Methods
16%
Surgical Procedures
16%
Colon Adenocarcinoma
16%
Screening Approach
16%
Conventional Treatment
16%
Female Patients
16%
Including 3D
16%
Bioprinting
16%
Microfluidic Platform
16%
Frequency of Occurrence
16%
Confounding Factors
16%
Multicellular Tumor Spheroids
16%
Biological Complexity
16%
Anticancer Drug Resistance
16%
Heterogeneity Factor
16%
Microscale Platforms
16%
Microscale Model
16%
On-chip Technology
16%
Major Challenges
16%
Sex Disparities
16%
Various Approaches
16%
Sex Bias
16%
Predictive Efficacy
16%
Conventional Assays
16%
Biased mutation
16%
Preclinical Platform
16%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
100%
Drug Discovery
100%
Tumor Model
100%
Malignant Neoplasm
71%
Drug Screening
57%
Neoplasm
28%
Drug Resistance
28%
Tumor Microenvironment
14%
Survival Rate
14%
Glioblastoma
14%
Drug Toxicity
14%
Colon Adenocarcinoma
14%